Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction.

MLA

Selvanesan, Benson Chellakkan, et al. “Lymphocyte Antigen 6K Signaling to Aurora Kinase Promotes Advancement of the Cell Cycle and the Growth of Cancer Cells, Which Is Inhibited by LY6K-NSC243928 Interaction.” Cancer Letters, vol. 558, Apr. 2023, p. 216094. EBSCOhost, https://doi.org/10.1016/j.canlet.2023.216094.

APA

Selvanesan, B. C., Varghese, S., Andrys-Olek, J., Arriaza, R. H., Prakash, R., Tiwari, P. B., Hupalo, D., Gusev, Y., Patel, M. N., Contente, S., Sanda, M., Uren, A., Wilkerson, M. D., Dalgard, C. L., Shimizu, L. S., Chruszcz, M., Borowski, T., & Upadhyay, G. (2023). Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction. Cancer Letters, 558, 216094. https://doi.org/10.1016/j.canlet.2023.216094

Chicago

Selvanesan, Benson Chellakkan, Sheelu Varghese, Justyna Andrys-Olek, Ricardo Hernandez Arriaza, Rahul Prakash, Purushottam Babu Tiwari, Daniel Hupalo, et al. 2023. “Lymphocyte Antigen 6K Signaling to Aurora Kinase Promotes Advancement of the Cell Cycle and the Growth of Cancer Cells, Which Is Inhibited by LY6K-NSC243928 Interaction.” Cancer Letters 558 (April): 216094. doi:10.1016/j.canlet.2023.216094.